Article for CME creditTreatment options and future prospects for the management of eyelid malignancies: An evidence-based update☆
Section snippets
Methods
The authors conducted a MEDLINE and PubMed literature search of articles published in English from 1966 through 1999. Search words included eyelid, basal cell carcinoma, squamous cell carcinoma, sebaceous gland carcinoma, malignant melanoma, Mohs’, radiation, cryotherapy, chemotherapy, therapy, and malignant eyelid tumor. Additional pertinent articles from a variety of textbooks and monographs were reviewed. In total, 110 articles and sources were reviewed.
As outlined by Wilkinson,2
Discussion
Current management of many anterior and posterior segment disorders is based on prospective and retrospective clinical studies. Ophthalmologists, both comprehensive and subspecialized, rely on data from these studies to determine the most appropriate and best clinical management. Many ophthalmologists, however, are not intimately familiar with the literature on which these clinical recommendations are founded. A recent study by Wilkinson,2 for example, affirmed that optimal trials regarding
Conclusions
Evidence-based medicine will continue to evolve as an important method to improve many aspects of medical care, including ophthalmology. For each of the four malignant eyelid tumors discussed in this paper, retrospective and prospective studies have provided important information and recommendations regarding treatment options and future prospects for their management. Based on these studies, the recommendations provided herein should help practitioners to diagnose and manage malignant eyelid
References (106)
- et al.
Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota
Ophthalmology
(1999) Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration
Ophthalmology
(2000)- et al.
Pigmented basal cell carcinomas of the eyelids
Am J Ophthalmol
(1981) - et al.
Periocular basal cell carcinoma in adults 35 years of age and younger
Am J Ophthalmol
(1988) - et al.
Squamous cell carcinoma of the eyelid
Surv Ophthalmol
(1986) - et al.
Sebaceous carcinomas of the ocular adnexaa clinicopathologic study of 104 cases with five-year follow-up data
Hum Pathol
(1982) - et al.
Multicentric sebaceous adenocarcinoma of the meibomian gland
Am J Ophthalmol
(1974) - et al.
Sebaceous carcinoma of the ocular adnexa
Surv Ophthalmol
(1989) - et al.
Basal cell carcinoma of the eyelid and periocular skin
Surv Ophthalmol
(1993) - et al.
Frozen section control in the surgery of basal cell carcinoma of the eyelid
Am J Ophthalmol
(1979)
Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy
Int J Radiat Oncol Biol Phys
Results of cryotherapy for eyelid malignancies
Am J Ophthalmol
Gamma-probe guided localization of lymph nodes
Surg Oncol
Recurrent and residual sebaceous carcinoma after Mohs’ excision of the primary lesion
Am J Ophthalmol
Conjunctival map biopsy to determine pagetoid spread
Am J Ophthalmol
Sebaceous carcinoma of the eyelids. The role of adjunctive cryotherapy in the management of conjunctival pagetoid spread
Ophthalmology
Primary radiation therapy for meibomian gland carcinoma
Am J Ophthalmol
Recurrence of sebaceous carcinoma of the eyelid after radiation therapy
Am J Ophthalmol
Management of cutaneous malignant melanoma by dermatologists of The American Academy of Dermatology. II. Definitive surgery for malignant melanoma
J Am Acad Dermatol
Limited or selective nodal dissection for malignant melanoma of the head and neck
Am J Surg
Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
Lancet
Adjuvant interferon-alpha in malignant melanomacurrent status
Cancer Treat Rev
Basal cell carcinoma
Tumor angiogenic factor and human skin tumors
Arch Dermatol
Malignant lesions of the eyelids
J Dermatol Surg Oncol
Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid
Am J Ophthalmol
Multiple nevoid basal-cell epithelioma, jaw cysts and bifid riba syndrome
N Engl J Med
Nevoid basal cell carcinoma syndromesome histologic observations on the cutaneous lesions
Arch Dermatol
The nevoid basal cell carcinoma syndromehistopathology of the basal cell tumors
J Cutan Pathol
Linear unilateral basal cell nevus with comedo-like lesions
Arch Dermatol
Surgical and aesthetic considerations of cancer of the skin in the Black American
J Dermatol Surg Oncol
Aggressive-growth basal cell carcinoma in young adults
Arch Dermatol
Xeroderma pigmentosumcutaneous, ocular, and neurologic abnormalities in 830 published cases
Arch Dermatol
Premalignant lesions and squamous cell carcinoma
Perineural invasion by squamous-cell carcinoma
J Dermatol Surg Oncol
The relative importance of risk factors in nonmelanoma carcinoma
Arch Dermatol
Sebaceous gland carcinomareview of 40 cases
Arch Ophthalmol
Sebaceous gland carcinoma of the eyelid following radiation therapy for cavernous hemangioma of the face
Arch Ophthalmol
Sebaceous gland carcinomaa subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma
Cancer
Sebaceous carcinoma of the eyelids, eyebrow, caruncle, and orbit
Trans Am Acad Ophthalmol Otolaryngol
Diagnosis and management of sebaceous gland carcinoma
Sebaceous carcinoma of the eyelidpitfalls in diagnosis
Ophthal Plast Reconstr Surg
Meibomian gland carcinoma presenting as a lacrimal gland tumor
Arch Ophthalmol
The melanocytecytology and cytochemistry
J Invest Dermatol
Pigmented lesions of the eyelid
The clinical diagnosis, classification, and histogenetic concepts of the early stages of cutaneous malignant melanomas
N Engl J Med
Melanotic freckle of Hutchinson
Cancer
The histiogenesis and biologic behavior of primary malignant melanomas of the skin
Cancer Res
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
Ann Surg
Basal cell carcinoma of the eyelidsa long-term follow-up study
Arch Ophthalmol
Cited by (0)
- ☆
Supported in part by an unrestricted grant from Research to Prevent Blindness, Inc., New York, New York.